Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus inhalation aerosol dose-ranging study in moderate persistent asthma
2004-001075-20Phase 2Completed
- Sponsor
- Fujisawa Pharmaceutical
- Start
- Jan 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in asthma, sponsored by Fujisawa Pharmaceutical. Started Jan 2005; status: completed.
02
Drugs
tacrolimus
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-001075-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001075-20.